NIH - Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01 Clinical Trial Optional)

Posted: July 20, 2020

Letter of Intent due October 10, 2020; Applications due November 10, 2020

This Funding Opportunity Announcement (FOA) invites applications that apply a cross-disciplinary and team science approach to gain comprehensive mechanistic understanding of the impact of sex differences on the trajectories of brain aging, phenotypes, and risk of Alzheimer's Disease (AD) and AD-related dementia (ADRD), and on precision medicine for treatment and prevention of AD/ADRD, including the responsiveness to pharmacologic and non-pharmacologic interventions.

See full solicitation here

Office of Grants and Contracts

Address

107 Ag Administration Building
University Park, PA 16802

Office of Grants and Contracts

Address

107 Ag Administration Building
University Park, PA 16802